Simple Summary Esophageal and esophagogastric junction cancers are not well explained
by traditional risk factors and have high mortality rates and limited treatment options. The …

Barrett's esophagus is a major complication of gastro-esophageal reflux disease and an
important precursor lesion for the development of Barrett's metaplasia and esophageal …

Background Campylobacter jejuni is the leading cause of zoonotic gastroenteritis. The other
emerging group of Campylobacters spp. are part of human oral commensal, represented by …

Campylobacter species are responsible for human gastroenteritis with diverse clinical
spectra, ranging from acute watery or bloody diarrhea to life-threatening autoimmune …

The gut and local esophageal microbiome progressively shift from healthy commensal
bacteria to inflammation-linked pathogenic bacteria in patients with gastroesophageal reflux …

Little is known of the relationships among paediatric upper gastrointestinal microbiotas, and
the impact of medication use and disease on their diversity. Here, we investigated the …

Gastroesophageal reflux disease (GERD), reflux esophagitis (RE), and peptic ulcer disease
(PUD) are commonly encountered in clinical practice. More than simple anatomic …

Background Gut microbiota (GM) have been proven associated with lots of gastrointestinal
diseases, but its causal relationship with Gastroesophageal reflux disease (GERD) and …

Proton pump inhibitors (PPIs) are currently routinely used for the treatment of reflux
esophagitis (RE); however, with frequent symptom recurrence after discontinuation and …

The microbiome is an emerging key co-factor in the development of esophageal cancer, the
sixth leading cause of cancer death worldwide. However, there is a paucity of data …